Literature DB >> 5818669

Treatment of dysthyroid ophthalmopathy with local guanethidine.

J S Cant, D R Lewis, M T Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5818669      PMCID： PMC1207305          DOI： 10.1136/bjo.53.4.233

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  2 in total

1.  Guanethidine (Ismelin) in ophthalmology. II. Clinical application in glaucoma.

Authors:  J A OOSTERHUIS
Journal:  Arch Ophthalmol       Date:  1962-06

2.  Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.

Authors:  A L Crombie; A A Lawson
Journal:  Br Med J       Date:  1967-12-09
  2 in total
  5 in total

1.  Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.

Authors:  Jun Soo Byun; Jeong Kyu Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-29       Impact factor: 3.117

2.  Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.

Authors:  N E Cartlidge; A L Crombie; J Anderson; R Hall
Journal:  Br Med J       Date:  1969-12-13

3.  Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.

Authors:  J S Cant; D R Lewis
Journal:  Br J Ophthalmol       Date:  1969-04       Impact factor: 4.638

4.  Dysthyroid ophthalmopathy: an update.

Authors:  L A Young
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

Review 5.  Thyroid-associated Ophthalmopathy.

Authors:  Esra Şahlı; Kaan Gündüz
Journal:  Turk J Ophthalmol       Date:  2017-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.